Use this identifier to quote or link this document: http://hdl.handle.net/2072/227460

Natalizumab versus Interferon B-1b to prevent CDMS in patients with CIS and poor prognostic factors: research protocol
Heredia Carqués, Cristina
Ramió Torrentà, Lluís
2014-03-28
Esclerosi múltiple
Multiple sclerosis
Demyelinating diseases
Attribution-NonCommercial-NoDerivs 3.0 Spain
http://creativecommons.org/licenses/by-nc-nd/3.0/es/
info:eu-repo/semantics/bachelorThesis
         

Show full item record

 

Coordination

 

Supporters